Global Poloxamer Market Growth 2023-2029

Global Poloxamer Market Growth 2023-2029

Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)).
LPI (LP Information)' newest research report, the “Poloxamer Industry Forecast” looks at past sales and reviews total world Poloxamer sales in 2022, providing a comprehensive analysis by region and market sector of projected Poloxamer sales for 2023 through 2029. With Poloxamer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poloxamer industry.
This Insight Report provides a comprehensive analysis of the global Poloxamer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poloxamer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Poloxamer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poloxamer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poloxamer.
The global Poloxamer market size is projected to grow from US$ 225 million in 2022 to US$ 278.8 million in 2029; it is expected to grow at a CAGR of 278.8 from 2023 to 2029.
Global major companies profiled in the Poloxamer market include BASF, Croda, etc. Global top two companies account for about 65% of the market share.
North America and Asia Pacific are likely to offer good prospects, the sum of the two market shares is about 70%.
In terms of product, Poloxamer 407 is the largest segment, with a share of nearly 30%. And according to the application, the largest application is Pharmaceutical Industry, followed by Cosmetics Industry, Biologics, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Poloxamer market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Poloxamer 124
Poloxamer 188
Poloxamer 338
Poloxamer 407
Poloxamer 184
Others
Segmentation by application
Pharmaceutical Industry
Cosmetics Industry
Biologics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BASF
Croda
Hubei Hengshuo
ADEKA
Solvay
Lakeland Chemicals
Nanjing Well
Merck KGaA

Key Questions Addressed in this Report
What is the 10-year outlook for the global Poloxamer market?
What factors are driving Poloxamer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poloxamer market opportunities vary by end market size?
How does Poloxamer break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.